Minzasolmin (UCB0599; (R)-NPT200-11) is an orally bioavailable compound that functions as an α-synuclein oligomerization inhibitor. By selectively binding to misfolded α-synuclein intermediates, it disrupts aggregation and fibril formation, thereby stabilizing their conformation. This mechanism effectively reduces the formation of pathological oligomers and blocks neurotoxic signaling, contributing to decreased α-synuclein accumulation in the brain. Preclinical studies demonstrated that Minzasolmin significantly improved motor deficits and reduced neuroinflammation, as well as α-synuclein-related pathology in transgenic mouse models.
Minzasolmin (UCB0599; (R)-NPT200-11) is an orally bioavailable compound that functions as an α-synuclein oligomerization inhibitor. By selectively binding to misfolded α-synuclein intermediates, it disrupts aggregation and fibril formation, thereby stabilizing their conformation. This mechanism effectively reduces the formation of pathological oligomers and blocks neurotoxic signaling, contributing to decreased α-synuclein accumulation in the brain. Preclinical studies demonstrated that Minzasolmin significantly improved motor deficits and reduced neuroinflammation, as well as α-synuclein-related pathology in transgenic mouse models.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
